Since it went on the market, the newer device has been the subject of several reports of hemolysis. This would seem ...
Please provide your email address to receive an email when new articles are posted on . A new generation of a balloon-expandable transcatheter aortic valve replacement system reduced paravalvular leak ...
Bioprosthetic valve fracture (BVF) was associated with a doubling of in-hospital mortality in patients undergoing valve-in-valve transcatheter aortic valve replacement (ViV TAVR), new registry data ...
Outcomes of Patients With Low-Flow Low-Gradient and Normal-Flow Low-Gradient Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement Receive the the latest news, research, and ...
ATLANTA -- For transcatheter aortic valve replacement (TAVR) candidates with a small aortic annulus, the two leading platforms offered differing hemodynamic valve performances despite being similarly ...
CASE 2 – Aortic Stenosis and Mitral Stenosis – When and How to Treat? Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the ...
Please provide your email address to receive an email when new articles are posted on . TAVR had similar clinical outcomes compared with surgery at 4 or 5 years in low-risk patients with severe aortic ...
While the first innovators in the area of minimally invasive cardiac procedures began introducing methods such as finger-fracture valvuloplasty as early as the 1920s — in the case of England’s Henry ...
NEW YORK--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement ...
Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability. HealthDay News — Seven-year follow-up data show that transcatheter aortic-valve ...
Two major players are vying for women’s hearts, but it’s not as romantic as it sounds. After Medtronic put forward a head-to-head study in April showing its transcatheter aortic valve replacement ...
BRISBANE, Australia & EAGAN, Minn.--(BUSINESS WIRE)--Anteris Technologies Ltd (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of TAVR and the world’s only balloon-expandable ...